In CRC cells, the IL-6/STAT3 axis promotes EMT and, therefore, the CRC aggressive phenotype via the STAT3-dependent transcriptional upregulation of Fos-related antigen-1 (Fra-1) TF. Here, IL6 is linked to colorectal carcinoma.